首页> 外文期刊>PDA journal of pharmaceutical science and technology >Application of Recombinant Factor C Reagent for the Detection of Bacterial Endotoxins in Pharmaceutical Products
【24h】

Application of Recombinant Factor C Reagent for the Detection of Bacterial Endotoxins in Pharmaceutical Products

机译:重组因子C试剂在药物产品中检测细菌内毒素的应用

获取原文
获取原文并翻译 | 示例
       

摘要

Recombinant Factor C (rFC) is non-animal-derived reagent used to detect bacterial endotoxins in pharmaceutical products. Despite the fact that the reagent was first commercially available nearly 15 years ago, the broad use of rFC in pharmaceutical industry has long been lagging, presumably due to historical single-source supplier concerns and the lack of inclusion in worldwide pharmacopeias. Commercial rFC reagents are now available from multiple manufacturers, thus single sourcing is no longer an issue. We report here the successful validation of several pharmaceutical products by an end-point florescence-based endotoxin method using the rFC reagent. The method is equivalent or superior to the compendia bacterial endotoxins test method. Based on the comparability data and extenuating circumstances, the incorporation of the end point fluorescence technique and rFC reagent in global compendia bacterial endotoxins test chapters is desired and warranted.
机译:重组因子C(RFC)是用于检测药物产品中的细菌内毒素的非动物衍生试剂。 尽管试剂是近15年前的首次可商购获得的,但由于历史单源供应商的历史担忧和缺乏全球药典缺乏,广泛使用RFC在制药行业的广泛使用。 商业RFC试剂现在可以从多个制造商提供,因此单一采购不再是一个问题。 我们在此报告了使用RFC试剂的基于终点荧光性的内毒素方法成功验证了几种药物产品。 该方法是等同的或优于Compendia细菌内毒素测试方法。 基于可比性数据和情景,期望掺入终点荧光技术和RFC试剂在全球COMBENDIA细菌内毒素测试章节中进行并保证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号